All Drugs Will Be Designed Using Artificial Intelligence By 2030 with Exscientia
Автор: Ai4
Загружено: 2024-08-21
Просмотров: 277
Anthony Bradley, VP, Design Development, Exscientia
Abstract:
Traditional drug development is characterized by a 96% failure rate and 10- to 15-year developmental timelines. Exscientia is flipping the script on the biopharma industry’s speed and success rate with its AI-driven, patient-first platform. In this talk, hear how the company is using its unique engineering platform and its physics and informatics toolbox to unlock challenging drug targets that have eluded science to date, deploying AI to solve complex design challenges for the first time in areas such as kinase selectivity, brain penetration, and allosteric inhibition.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: